The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy

被引:7
作者
Chambers, Anne E. [1 ]
Mills, Walter E. [1 ]
Mercade, Imma [2 ]
Crovetto, Francesca [3 ]
Crispi, Fatima [3 ]
Rodriguez-Revenga Bodi, Laia [4 ]
Pugia, Michael [5 ]
Mira, Aurea [6 ]
Lasalvia, Luis [7 ]
Banerjee, Subhasis [1 ]
Casals, Elena [2 ]
Gratacos, Eduard [3 ]
机构
[1] Biocity Scotland, Origin Biomarkers, Newhouse ML1 5UH, Lanarkshire, Scotland
[2] Hosp Clin Barcelona, E-08036 Barcelona, Spain
[3] Univ Barcelona, Hosp Clin, IDIBAPS, Dept Maternal Fetal Med,ICGON,Fetal & Perinatal M, E-08028 Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Mol Genet & Biochem, Barcelona, Spain
[5] Siemens Healthcare Diagnost, Elkhart, IN 46516 USA
[6] Hosp Clin Barcelona, Ctr Biomed Diag, Barcelona, Spain
[7] Siemens Healthcare Diagnost, New York, NY USA
关键词
hCG Receptor; sLHCGR; hCG-LHCGR; ELISA; Down's syndrome; Prenatal diagnosis; Screening test; Noninvasive prenatal test (NIPT); Early pregnancy; HUMAN CHORIONIC-GONADOTROPIN; PRENATAL-DIAGNOSIS; DNA; TRISOMY-21; ANEUPLOIDY; ERA;
D O I
10.1186/1471-2393-14-197
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Previous studies showed that soluble LHCGR/hCG-sLHCGR concentrations in serum or plasma combined with PAPP-A and free beta hCG significantly increased the sensitivity of Down's syndrome screen at early pregnancy without altering the false positive rate. The goal of the present study was to further examine the role of sLHCGR forms as combinatorial markers and to investigate whether sLHCGR could serve as an independent biomarker for Down's syndrome in first trimester pregnancy screens. Methods: The PAPP-A, free beta hCG, and hCG-sLHCGR concentrations together with nuchal translucency (NT) were measured in 40 Down's and 300 control pregnancies. The sLHCGR concentration was analysed in 40 Down's and 206 control pregnancies. Results: The hCG-LHCGR in combination with PAPP-A and free beta hCG increased the detection rate (DR) by 35% without altering the false positive rate (FPR). The sLHCGR: hCG-sLHCGR ratio alone detected 80% of Down's pregnancies in first trimester screening, with a false positive rate of 0.5%. Conclusions: While measurement of sLHCGR forms in combination with PAPP-A and free beta hCG significantly increases the detection rate of Down's syndrome at first trimester, the ratio of sLHCGR: hCG-sLHCGR acts as an independent marker with a detection rate that is significantly higher than the existing biochemical markers individually for prenatal first trimester screening of Down's syndrome.
引用
收藏
页数:5
相关论文
共 17 条
[1]   Noninvasive Prenatal Testing for Fetal Aneuploidy [J].
不详 .
OBSTETRICS AND GYNECOLOGY, 2012, 120 (06) :1532-1534
[2]   A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies [J].
Banerjee, S ;
Smallwood, A ;
Chambers, AE ;
Papageorghiou, A ;
Loosfelt, H ;
Spencer, K ;
Campbell, S ;
Nicolaides, K .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2005, 3 (1)
[3]   Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 [J].
Benn, Peter ;
Borrell, Antoni ;
Cuckle, Howard ;
Dugoff, Lorraine ;
Gross, Susan ;
Johnson, Jo-ann ;
Maymon, Ron ;
Odibo, Anthony ;
Schielen, Peter ;
Spencer, Kevin ;
Wright, Dave ;
Yaron, Yuval .
PRENATAL DIAGNOSIS, 2012, 32 (01) :1-2
[4]   Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down's syndrome, preterm delivery and preeclampsia [J].
Chambers, Anne E. ;
Griffin, Christopher ;
Naif, Samantha A. ;
Mills, Ian ;
Mills, Walter E. ;
Syngelaki, Argyro ;
Nicolaides, Kypros H. ;
Banerjee, Subhasis .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2012, 10
[5]   Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma [J].
Chiu, Rossa W. K. ;
Chan, K. C. Allen ;
Gao, Yuan ;
Lau, Virginia Y. M. ;
Zheng, Wenli ;
Leung, Tak Y. ;
Foo, Chris H. F. ;
Xie, Bin ;
Tsui, Nancy B. Y. ;
Lun, Fiona M. F. ;
Zee, Benny C. Y. ;
Lau, Tze K. ;
Cantor, Charles R. ;
Lo, Y. M. Dennis .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) :20458-20463
[6]   Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting [J].
Ehrich, Mathias ;
Deciu, Cosmin ;
Zwiefelhofer, Tricia ;
Tynan, John A. ;
Cagasan, Lesley ;
Tim, Roger ;
Lu, Vivian ;
McCullough, Ron ;
McCarthy, Erin ;
Nygren, Anders O. H. ;
Dean, Jarrod ;
Tang, Lin ;
Hutchison, Don ;
Lu, Tim ;
Wang, Huiquan ;
Angkachatchai, Vach ;
Oeth, Paul ;
Cantor, Charles R. ;
Bombard, Allan ;
van den Boom, Dirk .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (03)
[7]   Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood [J].
Fan, H. Christina ;
Blumenfeld, Yair J. ;
Chitkara, Usha ;
Hudgins, Louanne ;
Quake, Stephen R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (42) :16266-16271
[8]   ACMG position statement on prenatal/preconception expanded carrier screening [J].
Grody, Wayne W. ;
Thompson, Barry H. ;
Gregg, Anthony R. ;
Bean, Lora H. ;
Monaghan, Kristin G. ;
Schneider, Adele ;
Lebo, Roger V. .
GENETICS IN MEDICINE, 2013, 15 (06) :482-483
[9]   Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A [J].
Kagan, Karl O. ;
Wright, Dave ;
Valencia, Catalina ;
Maiz, Nerea ;
Nicolaides, Kypros H. .
HUMAN REPRODUCTION, 2008, 23 (09) :1968-1975
[10]   Modeling Down syndrome screening performance using first-trimester serum markers [J].
Koster, M. P. H. ;
Wortelboer, E. J. ;
Stoutenbeek, P. ;
Visser, G. H. A. ;
Schielen, P. C. J. I. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2011, 38 (02) :134-139